Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune tests in primary biliary cirrhosis.

C P Strassburg1, M P Manns

  • 1Department of Gastroenterology and Hepatology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Bailliere'S Best Practice & Research. Clinical Gastroenterology
|September 8, 2000
PubMed
Summary

Primary biliary cirrhosis (PBC) diagnosis relies heavily on serological tests, particularly antimitochondrial antibodies (AMA), for early detection and management. Identifying other autoantibodies is crucial for cases lacking AMA and for differentiating overlapping autoimmune liver diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The challenge of replicating putative genetic risk factors in a population-based database.

Journal of gastroenterology and hepatology·2024
Same author

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases.

ESMO open·2023
Same author

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients.

Journal of molecular medicine (Berlin, Germany)·2020
Same author

Dye chromoendoscopy leads to a higher adenoma detection in the duodenum and stomach in patients with familial adenomatous polyposis.

Endoscopy international open·2020
Same author

Parameters predicting COVID-19-induced myocardial injury and mortality.

Life sciences·2020
Same author

Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?

HIV medicine·2020

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Primary biliary cirrhosis (PBC) involves immune-mediated destruction of intrahepatic bile ducts, leading to cirrhosis and potential liver failure.
  • Early diagnosis of PBC is critical for timely treatment and assessing the need for liver transplantation.
  • Serological tests are paramount for PBC diagnosis, surpassing histology, biochemistry, or clinical presentation alone.

Purpose of the Study:

  • To highlight the diagnostic significance of serological markers in Primary Biliary Cirrhosis (PBC).
  • To discuss the role of antimitochondrial antibodies (AMA) and other autoantibodies in PBC diagnosis and management.
  • To address diagnostic challenges in overlapping autoimmune liver conditions.

Main Methods:

  • Review of serological testing strategies for PBC, focusing on autoantibody targets.

Related Experiment Videos

  • Analysis of the diagnostic utility and limitations of antimitochondrial antibodies (AMA).
  • Identification of alternative autoantibodies in AMA-negative PBC cases and overlapping syndromes.

    • Main Results:

    • Antimitochondrial antibodies (AMA) targeting the ketoacid dehydrogenase complex are highly specific for PBC.
    • AMA are useful for diagnosis but limited in predicting disease progression or transplantation needs.
    • PBC-specific antinuclear autoantibodies have been identified in AMA-negative patients.
    • Autoantibody profiles are essential for diagnosing PBC overlaps with autoimmune hepatitis and primary sclerosing cholangitis.

    Conclusions:

    • Serological autoantibody testing is the cornerstone of Primary Biliary Cirrhosis diagnosis.
    • While AMA are key, other autoantibodies are vital for comprehensive diagnosis, especially in complex or AMA-negative cases.
    • Accurate autoantibody determination aids in appropriate treatment strategies for PBC and related autoimmune liver diseases.